`
`Immunology: Chien et al.
`
`Proc. Natl. Acad. Sci. USA 86 (I989)
`
`l-——->vH
`S 1 0 7 TGTCCCAATCTTCACATTCAGAAATCAGCACTCAGTCCTGTCACTATGAAGTTGTGGTTAMCTGGGTTTTI‘CT'l'I‘TAACACTTTTACATGGTATCCAGTGTGAGGTGAAGCTGGTGGM l 2 O
`U10
`I
`HVl
`'
`SI 0 7 TCTGGAGGAGGCTTGGTACAGCCTGGGGGTTCTCTGAGACTCTCCTGTGCAACTTCTGGGTTCACCTTCAGTGATTTCTACATGGAGTGGGTCCGCCAGCCTCCAGGGAAGAGACTGGAG 2 4 0
`U10
`HV2
`Mg
`S 1 0 7 TGGATTGCTGCAAGTAGAAACAAAGCTMTGATTATACMCAGAGTACAGTGCATCTGTGAAGGGTCGGTTCATCGTCTCCAGAGACACTTCCCAAAGCATCCTCTACCTTCAGATGAAT 3 60
`
`U10
`D
`l—’CH1
`|—> JH T831
`SI 0 7 GCCCTGAGAGCTGAGGACACTGCCATTTATTACTGTGCMGAGATTACTACGGTAGTAGCTACTGGTACTTCGATGTCTGGGGCGCAGGGACCACGGTCACCGTCTCCTCAGAGTCTGCG 4 80
`U10 Asp
`(GCT)
`Ala
`S 1 0 7 AGAAATCCCACCATCTACCCACTGACACTCCCACCAGTCCTGTGCAGTGATCCCGTGATMTCGGCTGCCTGATTCACGA'I'I‘ACTTCCCTTTCGGCACGATGAATGTGACCTGGGGAAAG 6 00
`U10
`
`S 1 0 7 AGTGGGAAGGATATMCCACCGTGAACTTTCCACCTGCCCTCGCCTCTGGGGGACGGTACACCATGAGCAGCCAGTTAACCCTGCCAGCTGTCGAGTGCCCAGAAGGAGAGTCCGTGAAA 7 2 0
`
`010
`
`S 1 0 7 TGTTCCGTGCAACATGACTCTAACCCCGTCCAAGAATTGGATGTGAATTGCTCTG
`U1 0
`
`775
`
`FIG. 3. Sequence comparison of the rearranged H-chain genes of U10 and 8107. The nucleic acid sequence includes a portion of the 5 ’
`untranslated region and the leader. The V3, D, JH, and CH] domains of the U10 and 8107 genes are shown labeled at the fist base of each region.
`The solid line representing identity of the two sequences is interrupted by the altered codon (in parentheses) and the resulting amino acid
`substitution in U10. The fust (HVl) and second (HV2) hypervariable regions and the Tan site that is lost due to the base change are also shown.
`
`experiments, suggesting that the loss of antigen binding is
`associated with the H chain (23). Thus, the only sequence
`difference between the $107 and U10 V and adjoining C
`region domains is the substitution of an uncharged Ala for
`negatively charged Asp-101 in the fifth residue of 1H1.
`Significant Conformational Change in the U10 Binding Site.
`To examine the impact of the U10 mutation on V region
`structure, we examined the reactivity of a number of anti-
`idiotypic antibodies with the 8107 and U10 antibodies. Al-
`though eight difl‘erent anti-T15 monoclonal antibodies, spe-
`cific for nonbinding site surfaces of the V domain (29), did not
`distinguish between the U10 and 8107 proteins, polyclonal
`antibodies to the antigen-binding site of 8107 did (Fig. 4).
`Binding of a polyclonal antiserum to 8107 could be inhibited
`by the addition of either $107 or U2U4, a single-site mutant
`of 8107 exhibiting a significant decrease but not a complete
`loss of P-Cho binding (30). In contrast, much higher concen-
`trations of the U10 protein only partially inhibited $107
`binding (Fig. 4). The same results were obtained with three
`difi‘erent monoclonal anti-binding site antibodies, suggesting
`a conformational change in the U10 binding site.
`Computer Modeling of U10. The three-dimensional struc-
`ture of the V region ofthe U10 antibody was analyzed starting
`from the two crystallographic structures of the SlO7-like
`antibody McPC603 (10, 31). One had P-Cho bound and the
`
`
`o—o—o—o—.\.
`
`\.\
`
`0.7%-
`
`._.—
`
`0.1. ;\
`/.’//°
`0°405nm 23
`7.7g
`
`”'6
`
`V
`
`0.2
`0.l
`
`\
`
`PC
`
`10'
`IO
`I0'5
`I0‘4
`:04 10'? ur'
`Inhibitor Concentration (pg/ml)
`
`.
`
`I02
`
`:03
`
`FlG. 4. Determination of a conformational change in the binding
`site of U10 by competition ELISA. The ability of U10 (0), 8107 (o),
`and U2U4 (A) proteins to inhibit the binding of a binding-site-specific
`polyclonal antiserum to 8107 protein was tested. Binding is ex-
`pressed in 0D units. At the concentrations used, the polyclonal
`antiserum is inhibited 100% by P-Cho (I) as indicated.
`
`other a sulfate ion. A model of the 5107 V domain was built
`from the sulfate-bound McPC603 structure (Fig. 5A) by
`incorporating appropriate amino acid substitutions. Calcula-
`tions of the electrostatic potential on the molecular surface of
`the hapten and the V regions of the McPC603 structure and
`the 8107 model reveal strong electrostatic complementarity
`between the bound P-Cho hapten and the antibodies. These
`results quantitate local electrostatic stabilization of the hap-
`ten suggested in analyses of the crystal structure (10). Res-
`idues contributing most to the local eleCtrostatic complemen-
`tarity with P-Cho were all in VH2 Arg-52 with the phosphate
`moiety and Glu-35 and Asp-95 with the positively charged
`trimethylammonium group (see Fig. 5A).
`In the McPC603 structures, a hydrogen-bonded salt bridge
`in Va between the side chains of Asp-101 and Arg-94 forms
`at the surface of the antibody, with both side chains extending
`away from the active site, as seen in the model of $107 in Fig.
`5A. Asp-101 is 11.8 A distant from P—Cho, and Arg-94 is 9.3
`A distant. Disruption of this salt bridge due to the Ala-101
`mutation of U10 could affect the conformation of Arg-94 such
`that the Arg-94 side chain could extend into the negatively
`charged pocket that binds the positively charged trimethyl-
`ammonium moiety of P-Cho in the nonmutated antibody.
`Rotation of the whole length of the Arg side chain by 180°
`would allow the terminal nitrogen atoms to extend to within
`2 A of the P—Cho nitrogen in the bound complex.
`To explore this hypothesis, two models of the V region of
`the U10 protein, termed ARG-IN and ARG-OUT, were built
`from the 8107 model by substitution of Asp-101 with Ala by
`side-chain truncation. Computer graphics followed by a
`combination of template forcing, molecular dynamics, and
`full energy minimization, including explicit solvent mole-
`cules, yielded stereochemically reasonable structures. In the
`ARG-OUT model, the side-chain positions were maintained
`as in the McPC603 structure, while in the ARG-IN model, the
`Arg-94 side chain was moved into the P-Cho—binding site
`(Fig. SB). Since Arg-94 and Asp-95 are adjacent on a [3-
`strand, bringing Arg-94 into the binding pocket caused the
`Asp-95 side chain to extend out to the surface away from the
`binding pocket.
`Root-mean-square deviations of both ARG-OUT and
`ARG-IN from McPC603 framework main-chain positions
`were well within the range observed in immunoglobuhn
`crystal structures (21), suggesting that main-chain conforma-
`tional changes made in the ARG-IN model to accommodate
`the Arg-94 side-chain repositioning are plausible. Superpo-
`sition of individual immunoglobulin VL and V" domains onto
`
`

Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ ChargeStill Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.

This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.

One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site